Your browser doesn't support javascript.
loading
Targeting RAS signaling pathway as a potential therapeutic target in the treatment of colorectal cancer.
Bahrami, Afsane; Hassanian, Seyed Mahdi; ShahidSales, Soodabeh; Farjami, Zahra; Hasanzadeh, Malihe; Anvari, Kazem; Aledavood, Amir; Maftouh, Mina; Ferns, Gordon A; Khazaei, Majid; Avan, Amir.
Afiliação
  • Bahrami A; Department of Modern Sciences and Technologies, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Hassanian SM; Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • ShahidSales S; Department of Medical Biochemistry, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Farjami Z; Cancer Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Hasanzadeh M; Department of Modern Sciences and Technologies, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Anvari K; Department of Gynecology Oncology, Woman Health Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Aledavood A; Cancer Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Maftouh M; Cancer Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Ferns GA; Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Khazaei M; Brighton & Sussex Medical School, Division of Medical Education, Falmer, Brighton, Sussex, UK.
  • Avan A; Department of Physiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
J Cell Physiol ; 233(3): 2058-2066, 2018 Mar.
Article em En | MEDLINE | ID: mdl-28262927

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Proteínas Proto-Oncogênicas p21(ras) / Cetuximab / Antineoplásicos Imunológicos Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Proteínas Proto-Oncogênicas p21(ras) / Cetuximab / Antineoplásicos Imunológicos Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article